Position in MEDP
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$250,607,812
+$8,980,529 QoQ
Shares Held
473,211
-6.0% QoQ
Ownership
1.70%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#10
of 691 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $1,558,123,774 across 8 Diagnostics & Research names. MEDP ranks #3 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
2,284,127 | $342,687,571 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
645,648 | $323,702,080 | |
| 3 | MEDP |
Medpace Holdings, Inc.
This page
|
473,211 | $250,607,812 | |
| 4 | ILMN |
Illumina, Inc.
|
1,335,846 | $234,881,800 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
353,797 | $186,252,891 | |
| 6 | TWST |
Twist Bioscience Corp
|
1,086,779 | $111,807,822 | |
| 7 | BLLN |
BillionToOne, Inc.
|
901,420 | $108,152,369 | |
| 8 | DHR |
Danaher Corp /De/
|
165 | $31,429 |
All Filings in MEDP
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $250,607,812 | 473,211 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $241,627,283 | 503,191 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $307,266,357 | 547,078 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $300,678,709 | 584,796 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $163,926,880 | 522,293 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $1,310,775 | 4,302 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $4,812,682 | 14,486 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $4,965,608 | 14,876 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $2,223,165 | 5,398 | Shares | Defined | 2024-07-25 | |
| No filing history on record for this holder in this stock. | ||||||